Society guideline links: Multiple sclerosis and related disorders

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS)-Consortium of Multiple Sclerosis Centers (CMSC)-North American Imaging in Multiple Sclerosis Cooperative (NAIMS): Consensus recommendations on the use of MRI in patients with multiple sclerosis (2021)

●International recommendations on diagnosis and antibody testing for MOG encephalomyelitis (2018)

●International Panel for NMO Diagnosis (IPND): International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (2015)

●International Pediatric Multiple Sclerosis Study Group (IPMSSG): Criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders – Revisions to the 2007 definitions (2013)

United States

●Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS)-Consortium of Multiple Sclerosis Centers (CMSC)-North American Imaging in Multiple Sclerosis Cooperative (NAIMS): Consensus recommendations on the use of MRI in patients with multiple sclerosis (2021)

●American Academy of Neurology (AAN): Summary of evidence-based guideline – Complementary and alternative medicine in multiple sclerosis (2014, reaffirmed 2020)

●AAN: Evidence-based guideline – Assessment and management of psychiatric disorders in individuals with MS (2014, reaffirmed 2019)

●AAN: Practice guideline update summary – Vaccine-preventable infections and immunization in multiple sclerosis (2019)

●American Society for Blood and Marrow Transplantation (ASBMT): Position statement on autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis (2019)

●AAN: Practice guideline recommendations summary – Disease-modifying therapies for adults with multiple sclerosis (2018)

Europe

●Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS)-Consortium of Multiple Sclerosis Centers (CMSC)-North American Imaging in Multiple Sclerosis Cooperative (NAIMS): Consensus recommendations on the use of MRI in patients with multiple sclerosis (2021)

●European Academy of Neurology (EAN): Guideline on palliative care of people with severe, progressive multiple sclerosis (2020)

●European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS)/EAN: Guideline on the pharmacological treatment of people with multiple sclerosis (2018)

●MAGNIMS: Consensus recommendations on radiologically isolated syndrome or subclinical multiple sclerosis (2018)

●MAGNIMS: Consensus guidelines on MRI criteria for the diagnosis of multiple sclerosis (2016)

●MAGNIMS: Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis (2013)

●MAGNIMS: Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI (2011)

●European Federation of Neurological Societies (EFNS): Guidelines on diagnosis and management of neuromyelitis optica (2010)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on multiple sclerosis in adults – Management (2022)

Australia–New Zealand

●MS Australia: MS practice – For health professionals

Japan

●[In Japanese] Japanese Society of Neurology (JSN): Clinical practice guidelines on multiple sclerosis/optic neuromyelitis (2017)